May 12, 2026 07:43AM
Nov 18, 2025 07:51AM
Sep 15, 2025 08:01AM
Sep 15, 2025 08:00AM
Jul 21, 2025 07:00AM
Nov 20, 2024 07:00AM
Jul 11, 2024 07:00AM Renalytix and Steno Diabetes Center Announce Precision Medicine Collaboration Marking First Expansion for KidneyIntelX Platform Beyond US
Jun 27, 2024 06:30PM
Jun 14, 2024 07:02AM
Jun 14, 2024 07:00AM
May 15, 2024 07:00AM
Mar 14, 2024 07:00AM
Jan 10, 2024 07:00AM
Oct 6, 2023 07:00AM US Patent Office Allows Patent Claims for Intellectual Property Exclusively Licensed to Renalytix
Sep 28, 2023 07:00AM
Sep 7, 2023 07:00AM
Jul 21, 2023 07:01AM
Jul 21, 2023 07:00AM
Jun 29, 2023 06:01PM
Jun 9, 2023 07:00AM
Apr 19, 2023 07:00AM New Published Real-World Evidence Shows KidneyIntelX™ Utility
Apr 12, 2023 07:00AM
Mar 30, 2023 07:00AM
Feb 8, 2023 07:00AM
Jan 26, 2023 07:00AM
Jan 9, 2023 07:00AM
Dec 1, 2022 07:00AM
Nov 30, 2022 07:00AM Renalytix Reports Financial Results for First Quarter of Fiscal Year 2023
Nov 29, 2022 07:00AM
Nov 22, 2022 07:00AM
Nov 3, 2022 07:00AM
Oct 31, 2022 07:00AM
Oct 24, 2022 07:00AM
Oct 17, 2022 07:00AM
Sep 20, 2022 07:00AM Renalytix Announces Change to Board of Directors
Aug 8, 2022 07:00AM
Jun 30, 2022 07:00AM
Jun 23, 2022 07:00AM
Jun 10, 2022 07:06AM
Jun 10, 2022 07:00AM
Jun 6, 2022 07:00AM
Jun 2, 2022 07:00AM Renalytix Announces Two Data Presentations on KidneyIntelX™ at American Diabetes Association 82nd Scientific Sessions®
Apr 8, 2022 07:00AM
Apr 8, 2022 07:00AM
Mar 31, 2022 07:05AM
Mar 31, 2022 07:00AM
Mar 30, 2022 07:00AM
Mar 29, 2022 07:00AM
Mar 25, 2022 07:00AM Renalytix to Report Second Quarter and First Half Fiscal Year 2022 Financial Results on March 31
Mar 9, 2022 07:00AM

322,223 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All